NM_000168.6:c.4395delC
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000168.6(GLI3):c.4395delC(p.Ser1466AlafsTer22) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000168.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pallister-Hall syndrome;C0265306:Greig cephalopolysyndactyly syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change deletes 1 nucleotide from exon 15 of the GLI3 mRNA (c.4395delC), causing a frameshift at codon 1466. This creates a premature translational stop signal in the last exon of the GLI3 mRNA (p.Ser1466Alafs*22). While this is not anticipated to result in nonsense mediated decay, it is expected to result in a truncated GLI3 protein. This variant has not been reported in the literature. However a pathogenic frameshift variant (p.Thr1488Lysfs*23) occurs downstream of this frameshift (PMID: 24736735), which indicates truncation of the 3' end of the GLI3 protein is deleterious. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at